Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0160
+0.0010 (6.67%)
Mar 4, 2026, 4:10 PM AEST
Algorae Pharmaceuticals Revenue
Algorae Pharmaceuticals had revenue of -26.16K AUD in the twelve months ending December 31, 2025.
Revenue (ttm)
-26.16K
Revenue Growth
n/a
P/S Ratio
-979.32
Revenue / Employee
-544.98
Employees
48
Market Cap
25.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | 3.41K | -264.78K | -98.73% |
| Jun 30, 2021 | 268.18K | -285.51K | -51.56% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Neurotech International | 7.07M |
| Neurizon Therapeutics | 5.78M |
| Amplia Therapeutics | 5.01M |
| Tissue Repair | 3.26M |
| Proteomics International Laboratories | 3.21M |
| Noxopharm | 2.68M |
| Entropy Neurodynamics | 1.63M |
| Avecho Biotechnology | 1.24M |